nach oben

Acta Diabetologica

Erschienen in:

15.06.2019 | Review Article

New imaging systems in diabetic retinopathy

verfasst von: Maria Vittoria Cicinelli, Michele Cavalleri, Maria Brambati, Rosangela Lattanzio, Francesco Bandello

Erschienen in: Acta Diabetologica | Ausgabe 9/2019

Einloggen, um Zugang zu erhalten

Abstract

Various imaging modalities are of significant utility in the screening, grading, treatment, and follow-up of the different stages of diabetic retinopathy (DR) and diabetic macular edema. Color stereographic photography, fluorescein angiography, and optical coherence tomography (OCT) have been the gold standard for DR imaging for years. Besides these tools, newer technologies are gaining validation and popularity, such as fundus autofluorescence and OCT angiography. Furthermore, widefield retinography and ultra-widefield retinography have been introduced for a more comprehensive evaluation of the medium-far and very-far retinal peripheries, which is crucial for the assessment of the diverse manifestations of the disease. The aim of this review is to illustrate the recent advancements of the imaging systems for diagnosing DR, with a focus on the newest and noninvasive diagnostic tools.

Rathmann W, Giani G (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27(10):2568–2569 (author reply 2569) CrossRef

Leasher JL, Bourne RR, Flaxman SR et al (2016) Erratum. Global estimates on the number of people blind or visually impaired by diabetic retinopathy: a meta-analysis from 1990 to 2010. Diabetes Care 39:1643–1649. https://doi.org/10.2337/dc16-er11(Diabetes Care 39 (11):2096) CrossRefPubMed

Flaxman SR, Bourne RRA, Resnikoff S et al (2017) Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis. Lancet Glob Health. https://doi.org/10.1016/s2214-109x(17)30393-5 CrossRefPubMed

Bourne RRA, Flaxman SR, Braithwaite T et al (2017) Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis. Lancet Glob Health 5(9):e888–e897. https://doi.org/10.1016/S2214-109X(17)30293-0 CrossRefPubMed

Tong L, Vernon SA, Kiel W, Sung V, Orr GM (2001) Association of macular involvement with proliferative retinopathy in type 2 diabetes. Diabet Med 18(5):388–394CrossRef

Stefansson E, Bek T, Porta M, Larsen N, Kristinsson JK, Agardh E (2000) Screening and prevention of diabetic blindness. Acta Ophthalmol Scand 78(4):374–385CrossRef

Early Treatment Diabetic Retinopathy Study Research Group (1991) Classification of diabetic retinopathy from fluorescein angiograms ETDRS report number 11. Ophthalmology 98(5 Suppl):807–822

Abramoff MD, Fort PE, Han IC, Jayasundera KT, Sohn EH, Gardner TW (2018) Approach for a clinically useful comprehensive classification of vascular and neural aspects of diabetic retinal disease. Investig Ophthalmol Vis Sci 59(1):519–527. https://doi.org/10.1167/iovs.17-21873 CrossRef

Early Treatment Diabetic Retinopathy Study Research Group (1991) Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Ophthalmology 98(5 Suppl):823–833

10.

Rabiolo A, Parravano M, Querques L et al (2017) Ultra-wide-field fluorescein angiography in diabetic retinopathy: a narrative review. Clin Ophthalmol 11:803–807. https://doi.org/10.2147/OPTH.S133637 CrossRefPubMedPubMedCentral

11.

Ghasemi Falavarjani K, Tsui I, Sadda SR (2017) Ultra-wide-field imaging in diabetic retinopathy. Vis Res 139:187–190. https://doi.org/10.1016/j.visres.2017.02.009 CrossRefPubMed

12.

Early Treatment Diabetic Retinopathy Study Research Group (1991) Grading diabetic retinopathy from stereoscopic color fundus photographs–an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology 98(5 Suppl):786–806

13.

Staurenghi G, Viola F, Mainster MA, Graham RD, Harrington PG (2005) Scanning laser ophthalmoscopy and angiography with a wide-field contact lens system. Arch Ophthalmol 123(2):244–252. https://doi.org/10.1001/archopht.123.2.244 CrossRefPubMed

14.

Reeves GM, Kumar N, Beare NA, Pearce IA (2013) Use of Staurenghi lens angiography in the management of posterior uveitis. Acta Ophthalmol 91(1):48–51. https://doi.org/10.1111/j.1755-3768.2011.02200.x CrossRefPubMed

15.

Pomerantzeff O (1980) Wide-angle noncontact and small-angle contact cameras. Investig Ophthalmol Vis Sci 19(8):973–979

16.

Spaide RF (2011) Peripheral areas of nonperfusion in treated central retinal vein occlusion as imaged by wide-field fluorescein angiography. Retina 31(5):829–837. https://doi.org/10.1097/IAE.0b013e31820c841e CrossRefPubMed

17.

Witmer MT, Parlitsis G, Patel S, Kiss S (2013) Comparison of ultra-widefield fluorescein angiography with the Heidelberg Spectralis((R)) noncontact ultra-widefield module versus the Optos((R)) Optomap((R)). Clin Ophthalmol 7:389–394. https://doi.org/10.2147/OPTH.S41731 CrossRefPubMedPubMedCentral

18.

Silva PS, Cavallerano JD, Sun JK, Noble J, Aiello LM, Aiello LP (2012) Nonmydriatic ultrawide field retinal imaging compared with dilated standard 7-field 35-mm photography and retinal specialist examination for evaluation of diabetic retinopathy. Am J Ophthalmol 154(3):549–559. https://doi.org/10.1016/j.ajo.2012.03.019 CrossRefPubMed

19.

Wessel MM, Aaker GD, Parlitsis G, Cho M, D’Amico DJ, Kiss S (2012) Ultra-wide-field angiography improves the detection and classification of diabetic retinopathy. Retina 32(4):785–791. https://doi.org/10.1097/IAE.0b013e3182278b64 CrossRefPubMed

20.

Silva PS, Cavallerano JD, Tolls D et al (2014) Potential efficiency benefits of nonmydriatic ultrawide field retinal imaging in an ocular telehealth diabetic retinopathy program. Diabetes Care 37(1):50–55. https://doi.org/10.2337/dc13-1292 CrossRefPubMed

21.

Wessel MM, Nair N, Aaker GD, Ehrlich JR, D’Amico DJ, Kiss S (2012) Peripheral retinal ischaemia, as evaluated by ultra-widefield fluorescein angiography, is associated with diabetic macular oedema. Br J Ophthalmol 96(5):694–698. https://doi.org/10.1136/bjophthalmol-2011-300774 CrossRefPubMedPubMedCentral

22.

Silva PS, Cavallerano JD, Haddad NM et al (2015) Peripheral lesions identified on ultrawide field imaging predict increased risk of diabetic retinopathy progression over 4 years. Ophthalmology 122(5):949–956. https://doi.org/10.1016/j.ophtha.2015.01.008 CrossRefPubMed

23.

Patel RD, Messner LV, Teitelbaum B, Michel KA, Hariprasad SM (2013) Characterization of ischemic index using ultra-widefield fluorescein angiography in patients with focal and diffuse recalcitrant diabetic macular edema. Am J Ophthalmol 155(6):1038–1044. https://doi.org/10.1016/j.ajo.2013.01.007 CrossRefPubMed

24.

Fan W, Wang K, Ghasemi Falavarjani K et al (2017) Distribution of nonperfusion area on ultra-widefield fluorescein angiography in eyes with diabetic macular edema: DAVE study. Am J Ophthalmol 180:110–116. https://doi.org/10.1016/j.ajo.2017.05.024 CrossRefPubMed

25.

Oliver SC, Schwartz SD (2010) Peripheral vessel leakage (PVL): a new angiographic finding in diabetic retinopathy identified with ultra wide-field fluorescein angiography. Semin Ophthalmol 25(1–2):27–33. https://doi.org/10.3109/08820538.2010.481239 CrossRefPubMed

26.

Muqit MM, Marcellino GR, Henson DB et al (2013) Optos-guided pattern scan laser (Pascal)-targeted retinal photocoagulation in proliferative diabetic retinopathy. Acta Ophthalmol 91(3):251–258. https://doi.org/10.1111/j.1755-3768.2011.02307.x CrossRefPubMed

27.

Baker CW, Jiang Y, Stone T (2016) Recent advancements in diabetic retinopathy treatment from the Diabetic Retinopathy Clinical Research Network. Curr Opin Ophthalmol 27(3):210–216. https://doi.org/10.1097/ICU.0000000000000262 CrossRefPubMedPubMedCentral

28.

Aiello LP, Odia I, Glassman AR et al (2019) Comparison of Early Treatment Diabetic Retinopathy Study standard 7-field imaging with ultrawide-field imaging for determining severity of diabetic retinopathy. JAMA Ophthalmol 137(1):65–73. https://doi.org/10.1001/jamaophthalmol.2018.4982 CrossRefPubMed

29.

Pfau M, Goerdt L, Schmitz-Valckenberg S et al (2017) Green-light autofluorescence versus combined blue-light autofluorescence and near-infrared reflectance imaging in geographic atrophy secondary to age-related macular degeneration. Investig Ophthalmol Vis Sci 58(6):BIO121–BIO130. https://doi.org/10.1167/iovs.17-21764 CrossRef

30.

Sepah YJ, Akhtar A, Sadiq MA et al (2014) Fundus autofluorescence imaging: fundamentals and clinical relevance. Saudi J Ophthalmol 28(2):111–116. https://doi.org/10.1016/j.sjopt.2014.03.008 CrossRefPubMedPubMedCentral

31.

Pichi F, Abboud EB, Ghazi NG, Khan AO (2018) Fundus autofluorescence imaging in hereditary retinal diseases. Acta Ophthalmol 96(5):e549–e561. https://doi.org/10.1111/aos.13602 CrossRefPubMed

32.

Pece A, Isola V, Holz F, Milani P, Brancato R (2010) Autofluorescence imaging of cystoid macular edema in diabetic retinopathy. Ophthalmologica 224(4):230–235. https://doi.org/10.1159/000260229 CrossRefPubMed

33.

Ebrahimiadib N, Riazi-Esfahani M (2012) Autofluorescence imaging for diagnosis and follow-up of cystoid macular edema. J Ophthalmic Vis Res 7(3):261–267PubMedPubMedCentral

34.

Midena E, Bini S (2016) Multimodal retinal imaging of diabetic macular edema: toward new paradigms of pathophysiology. Graefes Arch Clin Exp Ophthalmol 254(9):1661–1668. https://doi.org/10.1007/s00417-016-3361-7 CrossRefPubMed

35.

Vujosevic S, Casciano M, Pilotto E, Boccassini B, Varano M, Midena E (2011) Diabetic macular edema: fundus autofluorescence and functional correlations. Investig Ophthalmol Vis Sci 52(1):442–448. https://doi.org/10.1167/iovs.10-5588 CrossRef

36.

Vujosevic S, Torresin T, Bini S et al (2017) Imaging retinal inflammatory biomarkers after intravitreal steroid and anti-VEGF treatment in diabetic macular oedema. Acta Ophthalmol 95(5):464–471. https://doi.org/10.1111/aos.13294 CrossRefPubMed

37.

Yoshitake S, Murakami T, Horii T et al (2014) Qualitative and quantitative characteristics of near-infrared autofluorescence in diabetic macular edema. Ophthalmology 121(5):1036–1044. https://doi.org/10.1016/j.ophtha.2013.11.033 CrossRefPubMed

38.

Reznicek L, Dabov S, Haritoglou C, Kampik A, Kernt M, Neubauer AS (2013) Green-light fundus autofluorescence in diabetic macular edema. Int J Ophthalmol 6(1):75–80. https://doi.org/10.3980/j.issn.2222-3959.2013.01.16 CrossRefPubMedPubMedCentral

39.

Tan AC, Fleckenstein M, Schmitz-Valckenberg S, Holz FG (2016) Clinical application of multicolor imaging technology. Ophthalmologica 236(1):8–18. https://doi.org/10.1159/000446857 CrossRefPubMed

40.

Ahmad MSZ, Carrim ZI (2017) Multicolor scanning laser imaging in diabetic retinopathy. Optom Vis Sci 94(11):1058–1061. https://doi.org/10.1097/OPX.0000000000001128 CrossRefPubMed

41.

Wanek J, Blair NP, Chau FY, Lim JI, Leiderman YI, Shahidi M (2016) Alterations in retinal layer thickness and reflectance at different stages of diabetic retinopathy by en face optical coherence tomography. Investig Ophthalmol Vis Sci 57(9):OCT341–OCT347. https://doi.org/10.1167/iovs.15-18715 CrossRef

42.

Cho YJ, Lee DH, Kim M (2018) Optical coherence tomography findings predictive of response to treatment in diabetic macular edema. J Int Med Res 46(11):4455–4464. https://doi.org/10.1177/0300060518798503 CrossRefPubMedPubMedCentral

43.

Sala-Puigdollers A, Figueras-Roca M, Hereu M et al (2018) Repeatability and reproducibility of retinal and choroidal thickness measurements in Diabetic Macular Edema using Swept-source Optical Coherence Tomography. PLoS ONE 13(7):e0200819. https://doi.org/10.1371/journal.pone.0200819 CrossRefPubMedPubMedCentral

44.

Schmidt-Erfurth U, Garcia-Arumi J, Bandello F et al (2017) Guidelines for the management of diabetic macular edema by the European Society of Retina Specialists (EURETINA). Ophthalmologica 237(4):185–222. https://doi.org/10.1159/000458539 CrossRefPubMed

45.

Parodi Battaglia M, Iacono P, Cascavilla M, Zucchiatti I, Bandello F (2018) A pathogenetic classification of diabetic macular edema. Ophthalmic Res 60(1):23–28. https://doi.org/10.1159/000484350 CrossRefPubMed

46.

Zur D, Iglicki M, Busch C et al (2018) OCT biomarkers as functional outcome predictors in diabetic macular edema treated with dexamethasone implant. Ophthalmology 125(2):267–275. https://doi.org/10.1016/j.ophtha.2017.08.031 CrossRefPubMed

47.

Vujosevic S, Berton M, Bini S, Casciano M, Cavarzeran F, Midena E (2016) Hyperreflective retinal spots and visual function after anti-vascular endothelial growth factor treatment in center-involving diabetic macular edema. Retina 36(7):1298–1308. https://doi.org/10.1097/IAE.0000000000000912 CrossRefPubMed

48.

Midena E, Pilotto E, Bini S (2018) Hyperreflective intraretinal foci as an OCT biomarker of retinal inflammation in diabetic macular edema. Investig Ophthalmol Vis Sci 59(13):5366. https://doi.org/10.1167/iovs.18-25611 CrossRef

49.

Yoon D, Rusu I, Barbazetto I (2014) Reduced effect of anti-vascular endothelial growth factor agents on diabetics with vitreomacular interface abnormalities. Int Ophthalmol 34(4):817–823. https://doi.org/10.1007/s10792-013-9884-6 CrossRefPubMed

50.

Gupta A, Raman R, Kulothungan V, Sharma T (2014) Association of systemic and ocular risk factors with neurosensory retinal detachment in diabetic macular edema: a case-control study. BMC Ophthalmol 14:47. https://doi.org/10.1186/1471-2415-14-47 CrossRefPubMedPubMedCentral

51.

Radwan SH, Soliman AZ, Tokarev J, Zhang L, van Kuijk FJ, Koozekanani DD (2015) Association of disorganization of retinal inner layers with vision after resolution of center-involved diabetic macular edema. JAMA Ophthalmol 133(7):820–825. https://doi.org/10.1001/jamaophthalmol.2015.0972 CrossRefPubMed

52.

Joltikov KA, Sesi CA, de Castro VM et al (2018) Disorganization of retinal inner layers (DRIL) and neuroretinal dysfunction in early diabetic retinopathy. Investig Ophthalmol Vis Sci 59(13):5481–5486. https://doi.org/10.1167/iovs.18-24955 CrossRef

53.

Sophie R, Lu N, Campochiaro PA (2015) Predictors of functional and anatomic outcomes in patients with diabetic macular edema treated with ranibizumab. Ophthalmology 122(7):1395–1401. https://doi.org/10.1016/j.ophtha.2015.02.036 CrossRefPubMed

54.

Sambhav K, Grover S, Chalam KV (2017) The application of optical coherence tomography angiography in retinal diseases. Surv Ophthalmol 62(6):838–866. https://doi.org/10.1016/j.survophthal.2017.05.006 CrossRefPubMed

55.

Khadamy J, Abri Aghdam K, Falavarjani KG (2018) An update on optical coherence tomography angiography in diabetic retinopathy. J Ophthalmic Vis Res 13(4):487–497. https://doi.org/10.4103/jovr.jovr_57_18 CrossRefPubMedPubMedCentral

56.

Ishibazawa A, Nagaoka T, Yokota H et al (2016) Characteristics of retinal neovascularization in proliferative diabetic retinopathy imaged by optical coherence tomography angiography. Investig Ophthalmol Vis Sci 57(14):6247–6255. https://doi.org/10.1167/iovs.16-20210 CrossRef

57.

Savastano MC, Federici M, Falsini B, Caporossi A, Minnella AM (2018) Detecting papillary neovascularization in proliferative diabetic retinopathy using optical coherence tomography angiography. Acta Ophthalmol 96(3):321–323. https://doi.org/10.1111/aos.13166 CrossRefPubMed

58.

Lee CS, Lee AY, Sim DA et al (2015) Reevaluating the definition of intraretinal microvascular abnormalities and neovascularization elsewhere in diabetic retinopathy using optical coherence tomography and fluorescein angiography. Am J Ophthalmol 159(1):101–110. https://doi.org/10.1016/j.ajo.2014.09.041 CrossRefPubMed

59.

Nesper PL, Roberts PK, Onishi AC et al (2017) Quantifying microvascular abnormalities with increasing severity of diabetic retinopathy using optical coherence tomography angiography. Investig Ophthalmol Vis Sci 58(6):BIO307–BIO315. https://doi.org/10.1167/iovs.17-21787 CrossRef

60.

Miwa Y, Murakami T, Suzuma K et al (2016) Relationship between functional and structural changes in diabetic vessels in optical coherence tomography angiography. Sci Rep 6:29064. https://doi.org/10.1038/srep29064 CrossRefPubMedPubMedCentral

61.

Couturier A, Mane V, Bonnin S et al (2015) Capillary plexus anomalies in diabetic retinopathy on optical coherence tomography angiography. Retina 35(11):2384–2391. https://doi.org/10.1097/IAE.0000000000000859 CrossRefPubMed

62.

Parravano M, De Geronimo D, Scarinci F et al (2017) Diabetic microaneurysms internal reflectivity on spectral-domain optical coherence tomography and optical coherence tomography angiography detection. Am J Ophthalmol 179:90–96. https://doi.org/10.1016/j.ajo.2017.04.021 CrossRefPubMed

63.

Al-Sheikh M, Akil H, Pfau M, Sadda SR (2016) Swept-source OCT angiography imaging of the foveal avascular zone and macular capillary network density in diabetic retinopathy. Investig Ophthalmol Vis Sci 57(8):3907–3913. https://doi.org/10.1167/iovs.16-19570 CrossRef

64.

Tarassoly K, Miraftabi A, Soltan Sanjari M, Parvaresh MM (2018) The relationship between foveal avascular zone area, vessel density, and cystoid changes in diabetic retinopathy: an optical coherence tomography angiography study. Retina 38(8):1613–1619. https://doi.org/10.1097/IAE.0000000000001755 CrossRefPubMed

65.

Garcia JM, Lima TT, Louzada RN, Rassi AT, Isaac DL, Avila M (2016) Diabetic macular ischemia diagnosis: comparison between optical coherence tomography angiography and fluorescein angiography. J Ophthalmol 2016:3989310. https://doi.org/10.1155/2016/3989310 CrossRefPubMedPubMedCentral

66.

Scarinci F, Nesper PL, Fawzi AA (2016) Deep retinal capillary nonperfusion is associated with photoreceptor disruption in diabetic macular ischemia. Am J Ophthalmol 168:129–138. https://doi.org/10.1016/j.ajo.2016.05.002 CrossRefPubMedPubMedCentral

67.

Thompson IA, Durrani AK, Patel S (2018) Optical coherence tomography angiography characteristics in diabetic patients without clinical diabetic retinopathy. Eye (Lond). https://doi.org/10.1038/s41433-018-0286-x CrossRef

68.

Magrath GN, Say EAT, Sioufi K, Ferenczy S, Samara WA, Shields CL (2017) Variability in foveal avascular zone and capillary density using optical coherence tomography angiography machines in healthy eyes. Retina 37(11):2102–2111. https://doi.org/10.1097/IAE.0000000000001458 CrossRefPubMed

69.

Spaide RF, Fujimoto JG, Waheed NK (2015) Image artifacts in optical coherence tomography angiography. Retina 35(11):2163–2180. https://doi.org/10.1097/IAE.0000000000000765 CrossRefPubMedPubMedCentral

70.

Wong TY, Sun J, Kawasaki R et al (2018) Guidelines on diabetic eye care: the international council of ophthalmology recommendations for screening, follow-up, referral, and treatment based on resource settings. Ophthalmology 125(10):1608–1622. https://doi.org/10.1016/j.ophtha.2018.04.007 CrossRefPubMed

71.

Liu Y, Zupan NJ, Shiyanbola OO et al (2018) Factors influencing patient adherence with diabetic eye screening in rural communities: a qualitative study. PLoS ONE 13(11):e0206742. https://doi.org/10.1371/journal.pone.0206742 CrossRefPubMedPubMedCentral

72.

Chin EK, Ventura BV, See KY, Seibles J, Park SS (2014) Nonmydriatic fundus photography for teleophthalmology diabetic retinopathy screening in rural and urban clinics. Telemed J E Health 20(2):102–108. https://doi.org/10.1089/tmj.2013.0042 CrossRefPubMedPubMedCentral

73.

DeTore J, Rizzolo D (2018) Telemedicine and diabetic retinopathy. JAAPA 31(9):1–5. https://doi.org/10.1097/01.JAA.0000544310.25116.97 CrossRefPubMed

74.

Wilson C, Horton M, Cavallerano J, Aiello LM (2005) Addition of primary care-based retinal imaging technology to an existing eye care professional referral program increased the rate of surveillance and treatment of diabetic retinopathy. Diabetes Care 28(2):318–322CrossRef

75.

Shi L, Wu H, Dong J, Jiang K, Lu X, Shi J (2015) Telemedicine for detecting diabetic retinopathy: a systematic review and meta-analysis. Br J Ophthalmol 99(6):823–831. https://doi.org/10.1136/bjophthalmol-2014-305631 CrossRefPubMedPubMedCentral

76.

Rachapelle S, Legood R, Alavi Y et al (2013) The cost-utility of telemedicine to screen for diabetic retinopathy in India. Ophthalmology 120(3):566–573. https://doi.org/10.1016/j.ophtha.2012.09.002 CrossRefPubMed

77.

Lee JY, Lee SWH (2018) Telemedicine cost-effectiveness for diabetes management: a systematic review. Diabetes Technol Ther 20(7):492–500. https://doi.org/10.1089/dia.2018.0098 CrossRefPubMed

78.

Nathoo N, Ng M, Rudnisky CJ, Tennant MT (2010) The prevalence of diabetic retinopathy as identified by teleophthalmology in rural Alberta. Can J Ophthalmol 45(1):28–32. https://doi.org/10.3129/i09-220 CrossRefPubMed

79.

Boucher MC, Nguyen QT, Angioi K (2005) Mass community screening for diabetic retinopathy using a nonmydriatic camera with telemedicine. Can J Ophthalmol 40(6):734–742. https://doi.org/10.1016/S0008-4182(05)80091-2 CrossRefPubMed

80.

Bursell SE, Fonda SJ, Lewis DG, Horton MB (2018) Prevalence of diabetic retinopathy and diabetic macular edema in a primary care-based teleophthalmology program for American Indians and Alaskan Natives. PLoS ONE 13(6):e0198551. https://doi.org/10.1371/journal.pone.0198551 CrossRefPubMedPubMedCentral

81.

Andonegui J, Serrano L, Eguzkiza A et al (2010) Diabetic retinopathy screening using tele-ophthalmology in a primary care setting. J Telemed Telecare 16(8):429–432. https://doi.org/10.1258/jtt.2010.091204 CrossRefPubMed

82.

Scanlon PH (2017) The english national screening programme for diabetic retinopathy 2003–2016. Acta Diabetol 54(6):515–525. https://doi.org/10.1007/s00592-017-0974-1 CrossRefPubMedPubMedCentral

83.

Liew G, Michaelides M, Bunce C (2014) A comparison of the causes of blindness certifications in England and Wales in working age adults (16–64 years), 1999–2000 with 2009–2010. BMJ Open 4(2):e004015. https://doi.org/10.1136/bmjopen-2013-004015 CrossRefPubMedPubMedCentral

84.

Kim J, Driver DD (2015) Teleophthalmology for first nations clients at risk of diabetic retinopathy: a mixed methods evaluation. JMIR Med Inform 3(1):e10. https://doi.org/10.2196/medinform.3872 CrossRefPubMedPubMedCentral

85.

Salongcay RP, Silva PS (2018) The role of teleophthalmology in the management of diabetic retinopathy. Asia Pac J Ophthalmol (Phila) 7(1):17–21. https://doi.org/10.22608/APO.2017479 CrossRef

86.

Fenner BJ, Wong RLM, Lam WC, Tan GSW, Cheung GCM (2018) Advances in retinal imaging and applications in diabetic retinopathy screening: a review. Ophthalmol Ther 7(2):333–346. https://doi.org/10.1007/s40123-018-0153-7 CrossRefPubMedPubMedCentral

87.

Gulshan V, Peng L, Coram M et al (2016) Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs. JAMA 316(22):2402–2410. https://doi.org/10.1001/jama.2016.17216 CrossRefPubMed

88.

Gargeya R, Leng T (2017) Automated identification of diabetic retinopathy using deep learning. Ophthalmology 124(7):962–969. https://doi.org/10.1016/j.ophtha.2017.02.008 CrossRefPubMed

89.

Ting DSW, Cheung CY, Lim G et al (2017) Development and validation of a deep learning system for diabetic retinopathy and related eye diseases using retinal images from multiethnic populations with diabetes. JAMA 318(22):2211–2223. https://doi.org/10.1001/jama.2017.18152 CrossRefPubMedPubMedCentral

90.

Krause J, Gulshan V, Rahimy E et al (2018) Grader variability and the importance of reference standards for evaluating machine learning models for diabetic retinopathy. Ophthalmology 125(8):1264–1272. https://doi.org/10.1016/j.ophtha.2018.01.034 CrossRefPubMed

Titel: New imaging systems in diabetic retinopathy
verfasst von: Maria Vittoria Cicinelli
Michele Cavalleri
Maria Brambati
Rosangela Lattanzio
Francesco Bandello
Publikationsdatum: 15.06.2019
Verlag: Springer Milan
Erschienen in: Acta Diabetologica / Ausgabe 9/2019
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI: https://doi.org/10.1007/s00592-019-01373-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

New imaging systems in diabetic retinopathy

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2019

Prediabetes defined by HbA1c and by fasting glucose: differences in risk factors and prevalence

Different treatment forms of type II diabetes and the risk of dementia in German health claims data

MELAS requires broad clinical and genetic work-up

Reply to Josef Finsterer “MELAS requires broad clinical and genetic work-up”

Pharmacological blockade of the P2X7 receptor reverses retinal damage in a rat model of type 1 diabetes

High level of clinical inertia in insulin initiation in type 2 diabetes across Central and South-Eastern Europe: insights from SITIP study

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin